Co-Authors
This is a "connection" page, showing publications co-authored by Jerzy Bodurka and T Teague.
Connection Strength
0.760
-
Common Data Elements, Scalable Data Management Infrastructure, and Analytics Workflows for Large-Scale Neuroimaging Studies. Front Psychiatry. 2021; 12:682495.
Score: 0.194
-
Identification and replication of RNA-Seq gene network modules associated with depression severity. Transl Psychiatry. 2018 09 05; 8(1):180.
Score: 0.160
-
Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorder. Neuropsychopharmacology. 2021 04; 46(5):928-938.
Score: 0.047
-
A hidden menace? Cytomegalovirus infection is associated with reduced cortical gray matter volume in major depressive disorder. Mol Psychiatry. 2021 08; 26(8):4234-4244.
Score: 0.047
-
Diagnosis-independent loss of T-cell costimulatory molecules in individuals with cytomegalovirus infection. Brain Behav Immun. 2020 07; 87:795-803.
Score: 0.044
-
Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020 07; 25(7):1457-1468.
Score: 0.039
-
Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression. Brain Behav Immun. 2018 Jan; 67:59-64.
Score: 0.037
-
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav Immun. 2016 Aug; 56:335-42.
Score: 0.034
-
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun. 2016 Mar; 53:39-48.
Score: 0.033
-
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Psychoneuroendocrinology. 2015 Dec; 62:54-8.
Score: 0.032
-
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun. 2015 May; 46:55-9.
Score: 0.031
-
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology. 2015 Feb; 52:200-11.
Score: 0.031
-
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology. 2015 Jan; 40(2):463-71.
Score: 0.030